Welcome! For price inquiries, please feel free to contact us through the form below. We will get back to you as soon as possible.

See All CTLA4 Related Kits

Specification Related Products

Cat.No. :	Kit-1713
Product Overview :	B7-2 (CD86) signaling through CTLA4(CD152) has been shown to inhibit T cell activation. This co-inhibitory pathway can be overactive in many tumors, enabling cancers to escape the host"s immune system. CTLA4-blocking antibodies, including Ipilimumab (Yervoy) and Tremelimumab, have shown clinical efficacy in treating cancer.
Size :	96 reactions
Applications :	This kit is useful for screening for inhibitors of CTLA4 binding to B7-2.
Storage :	Stable at least 6 months from date of receipt, when stored as directed. Kit components require different storage conditions. Be sure to store each component at the proper temperature upon arrival